[1] |
CAMPBELL R S, BROBST D, BISGARD G. Intestinal lymphangiectasia in a dog[J]. J Am Vet Med Assoc, 1968, 153(8):1051-1054.
|
[2] |
JABLONSKI S A. Pathophysiology, diagnosis, and management of canine intestinal lymphangiectasia:a comparative review[J]. Animals, 2022, 12(20):2791.
|
[3] |
ALLENSPACH K, IENNARELLA-SERVANTEZ C. Canine protein losing enteropathies and systemic complications[J]. Vet Clin North Am Small Anim Pract, 2021, 51(1):111-122.
|
[4] |
KULL P A, HESS R S, CRAIG L E, et al. Clinical, clinicopathologic, radiographic, and ultrasonographic characteristics of intestinal lymphangiectasia in dogs:17 cases (1996-1998)[J]. J Am Vet Med Assoc, 2001, 219(2):197-202.
|
[5] |
CRAVEN M D, WASHABAU R J. Comparative pathophysiology and management of protein-losing enteropathy[J]. J Vet Intern Med, 2019, 33(2):383-402.
|
[6] |
DOSSIN O, LAVOUÉ R. Protein-losing enteropathies in dogs[J]. Vet Clin North Am Small Anim Pract, 2011, 41(2):399-418.
|
[7] |
LITTMAN M P, DAMBACH D M, VADEN S L, et al. Familial protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers:222 cases (1983-1997)[J]. J Vet Intern Med, 2000, 14(1):68-80.
|
[8] |
SIMMERSON S M, ARMSTRONG P J, WVNSCHMANN A, et al. Clinical features, intestinal histopathology, and outcome in protein-losing enteropathy in Yorkshire Terrier dogs[J]. J Vet Intern Med, 2014, 28(2):331-337.
|
[9] |
JABLONSKI WENNOGLE S A, PRIESTNALL S L, WEBB C B. Histopathologic characteristics of intestinal biopsy samples from dogs with chronic inflammatory enteropathy with and without hypoalbuminemia[J]. J Vet Intern Med, 2017, 31(2):371-376.
|
[10] |
LARSON R N, GINN J A, BELL C M, et al. Duodenal endoscopic findings and histopathologic confirmation of intestinal lymphangiectasia in dogs[J]. J Vet Intern Med, 2012, 26(5):1087-1092.
|
[11] |
JABLONSKI WENNOGLE S A, PRIESTNALL S L, SUÁREZ-BONNET A, et al. Comparison of clinical, clinicopathologic, and histologic variables in dogs with chronic inflammatory enteropathy and low or normal serum 25-hydroxycholecalciferol concentrations[J]. J Vet Intern Med, 2019, 33(5):1995-2004.
|
[12] |
ROSSI G, CERQUETELLA M, ANTONELLI E, et al. The importance of histologic parameters of lacteal involvement in cases of canine lymphoplasmacytic enteritis[J]. Gastroenterol Hepatol Bed Bench, 2015, 8(1):33-41.
|
[13] |
JABLONSKI WENNOGLE S A, PRIESTNALL S L, SUÁREZ-BONNET A, et al. Lymphatic endothelial cell immunohistochemical markers for evaluation of the intestinal lymphatic vasculature in dogs with chronic inflammatory enteropathy[J]. J Vet Intern Med, 2019, 33(4):1669-1676.
|
[14] |
TOLBERT M K, MURPHY M, GAYLORD L, et al. Dietary management of chronic enteropathy in dogs[J]. J Small Anim Pract, 2022, 63(6):425-434.
|
[15] |
JABLONSKI WENNOGLE S A, STOCKMAN J, WEBB C B. Prospective evaluation of a change in dietary therapy in dogs with steroid-resistant protein-losing enteropathy[J]. J Small Anim Pract, 2021, 62(9):756-764.
|
[16] |
RUDINSKY A J, HOWARD J P, BISHOP M A, et al. Dietary management of presumptive protein-losing enteropathy in Yorkshire terriers[J]. J Small Anim Pract, 2017, 58(2):103-108.
|
[17] |
OKANISHI H, YOSHIOKA R, KAGAWA Y, et al. The clinical efficacy of dietary fat restriction in treatment of dogs with intestinal lymphangiectasia[J]. J Vet Intern Med, 2014, 28(3):809-817.
|